MicroRNA-124a regulates the differentiation of bone marrow mesenchymal stem cells into neurons

References

• Chiam K, Lee L, Kuo PH, et al. Brain PET and cerebrovascular disease. PET Clin. 2023;18(1):115–122. doi: 10.1016/j.cpet.2022.09.007.
   PubMed Web of Science ®Google Scholar
• Chlebiej M, Zurada A, Gielecki J, et al. Customizable tubular model for n-furcating blood vessels and its application to 3D reconstruction of the cerebrovascular system. Med Biol Eng Comput. 2023;61(6):1363. doi: 10.1007/s11517-022-02735-5.
   PubMed Web of Science ®Google Scholar
• Bhardwaj S, Craven BA, Sever JE, et al. Modeling flow in an in vitro anatomical cerebrovascular model with experimental validation. bioRxiv. 2023.
   Google Scholar
• De Silva TM, Faraci FM. The DOCA-Salt model of hypertension for studies of cerebrovascular function, stroke, and brain health. Methods Mol Biol. 2023;2616:481–487.
   PubMedGoogle Scholar
• Hendrix P, Melamed I, Weiner GM, et al. Transradial versus transfemoral intraoperative cerebral angiography for open cerebrovascular surgery: effectiveness, safety, and learning curve. Oper Neurosurg. 2022;24(5):476–482. doi: 10.1227/ons.0000000000000567.
   Web of Science ®Google Scholar
• Kossen T, Madai VI, Mutke MA, et al. Image-to-image generative adversarial networks for synthesizing perfusion parameter maps from DSC-MR images in cerebrovascular disease. Front Neurol. 2022;13:1051397. doi: 10.3389/fneur.2022.1051397.
   PubMed Web of Science ®Google Scholar
• Guo Y, Peng Y, Zeng H, et al. Progress in mesenchymal stem cell therapy for ischemic stroke. Stem Cells Int. 2021;2021:9923566. doi: 10.1155/2021/9923566.
   PubMed Web of Science ®Google Scholar
• Tan N, Xin W, Huang M, et al. Mesenchymal stem cell therapy for ischemic stroke: novel insight into the crosstalk with immune cells. Front Neurol. 2022;13:1048113. doi: 10.3389/fneur.2022.1048113.
   PubMed Web of Science ®Google Scholar
• Li J, Zhang Q, Wang W, et al. Mesenchymal stem cell therapy for ischemic stroke: a look into treatment mechanism and therapeutic potential. J Neurol. 2021;268(11):4095–4107. doi: 10.1007/s00415-020-10138-5.
   PubMed Web of Science ®Google Scholar
• Wang J, Zhang X, Chen H, et al. Engineered stem cells by emerging biomedical stratagems. Sci Bull (Beijing). 2023;S2095-9273(23)00848-4. Epub ahead of print. doi: 10.1016/j.scib.2023.12.006.
   Web of Science ®Google Scholar
• Zhou L, Wang J, Huang J, et al. The role of mesenchymal stem cell transplantation for ischemic stroke and recent research developments. Front Neurol. 2022;13:1000777. doi: 10.3389/fneur.2022.1000777.
   PubMed Web of Science ®Google Scholar
• Grobbelaar S, Mercier AE, van den Bout I, et al. Considerations for enhanced mesenchymal stromal/stem cell myogenic commitment in vitro. Clin Transl Sci. 2023. Epub ahead of print. doi: 10.1111/cts.13703.
   PubMed Web of Science ®Google Scholar
• Wu H, Fan Y, Zhang M. Advanced progress in the role of adipose-derived mesenchymal stromal/stem cells in the application of central nervous system disorders. Pharmaceutics. 2023;15(11):2637. doi: 10.3390/pharmaceutics15112637.
   PubMed Web of Science ®Google Scholar
• Gan C, Ouyang F. Exosomes released from bone-marrow stem cells ameliorate hippocampal neuronal injury through transferring miR-455-3p. J Stroke Cerebrovasc Dis. 2022;31(8):106142. doi: 10.1016/j.jstrokecerebrovasdis.2021.106142.
   PubMed Web of Science ®Google Scholar
• Hou K, Li G, Zhao J, et al. Bone mesenchymal stem cell-derived exosomal microRNA-29b-3p prevents hypoxic-ischemic injury in rat brain by activating the PTEN-mediated akt signaling pathway. J Neuroinflammation. 2020;17(1):46. doi: 10.1186/s12974-020-1725-8.
   PubMed Web of Science ®Google Scholar
• Kuang Y, Zheng X, Zhang L, et al. Adipose-derived mesenchymal stem cells reduce autophagy in stroke mice by extracellular vesicle transfer of miR-25. J Extracell Vesicles. 2020;10(1):e12024. doi: 10.1002/jev2.12024.
   PubMed Web of Science ®Google Scholar
• Mondanizadeh M, Arefian E, Mosayebi G, et al. MicroRNA-124 regulates neuronal differentiation of mesenchymal stem cells by targeting Sp1 mRNA. J Cell Biochem. 2015;116(6):943–953. doi: 10.1002/jcb.25045.
   PubMed Web of Science ®Google Scholar
• Min W, Wu Y, Fang Y, et al. Bone marrow mesenchymal stem cells-derived exosomal microRNA-124-3p attenuates hypoxic-ischemic brain damage through depressing tumor necrosis factor receptor associated factor 6 in newborn rats. Bioengineered. 2022;13(2):3194–3206. doi: 10.1080/21655979.2021.2016094.
   PubMed Web of Science ®Google Scholar
• Song JL, Zheng W, Chen W, et al. Lentivirus-mediated microRNA-124 gene-modified bone marrow mesenchymal stem cell transplantation promotes the repair of spinal cord injury in rats. Exp Mol Med. 2017;49(5):e332–e332. doi: 10.1038/emm.2017.48.
   PubMedGoogle Scholar
• Chen L, Kong C. LINC00173 regulates polycystic ovarian syndrome progression by promoting apoptosis and repressing proliferation in ovarian granulosa cells via the microRNA-124-3p (miR-124-3p)/jagged canonical notch ligand 1 (JAG1) pathway. Bioengineered. 2022;13(4):10373–10385. doi: 10.1080/21655979.2022.2053797.
   PubMed Web of Science ®Google Scholar
• Konrad KD, Song JL. microRNA-124 regulates notch and NeuroD1 to mediate transition states of neuronal development. Dev Neurobiol. 2023;83(1–2):3–27.
   PubMed Web of Science ®Google Scholar
• Liu GY, Wu Y, Kong FY, et al. BMSCs differentiated into neurons, astrocytes and oligodendrocytes alleviated the inflammation and demyelination of EAE mice models. PLoS One. 2021;16(5):e0243014. doi: 10.1371/journal.pone.0243014.
   PubMed Web of Science ®Google Scholar
• Zhang P, Zhang H, Lin J, et al. Insulin impedes osteogenesis of BMSCs by inhibiting autophagy and promoting premature senescence via the TGF-β1 pathway. Aging. 2020;12(3):2084–2100. doi: 10.18632/aging.102723.
   PubMedGoogle Scholar
• Kremer C, Lorenzano S, Kruuse C. Editorial: sex differences in cerebrovascular diseases. Front Neurol. 2022;13:1128177. doi: 10.3389/fneur.2022.1128177.
   PubMed Web of Science ®Google Scholar
• Lapointe T, Houle J, Sia YT, et al. Addition of high-intensity interval training to a moderate intensity continuous training cardiovascular rehabilitation program after ischemic cerebrovascular disease: a randomized controlled trial. Front Neurol. 2022;13:963950. doi: 10.3389/fneur.2022.963950.
   PubMed Web of Science ®Google Scholar
• Nickoles TA, Lewit RA, Notrica DM, et al. Diagnostic accuracy of screening tools for pediatric blunt cerebrovascular injury: an ATOMAC multicenter study. J Trauma Acute Care Surg. 2023;95(3):327–333. doi: 10.1097/TA.0000000000003888.
   PubMed Web of Science ®Google Scholar
• Sanchez-Porras R, Ramírez-Cuapio FL, Hecht N, et al. Cerebrovascular pressure reactivity according to Long-Pressure reactivity index during spreading depolarizations in aneurysmal subarachnoid hemorrhage. Neurocrit Care. 2023;39(1):135–144. doi: 10.1007/s12028-022-01669-y.
   PubMed Web of Science ®Google Scholar
• Olagunju A, Mihyawi N, Fath AR, et al. The relative risk of ischemic cerebrovascular accident in patients with von willebrand disease. J Investig Med. 2023;71(4):394–399. doi: 10.1177/10815589221150642.
   PubMed Web of Science ®Google Scholar
• Nazari B, Soleimani M, Ebrahimi-Barough S, et al. Overexpression of mir-219 promotes differentiation of human induced pluripotent stem cells into pre-oligodendrocyte. J Chem Neuroanat. 2018;91:8–16. doi: 10.1016/j.jchemneu.2018.03.001.
   PubMed Web of Science ®Google Scholar
• Nazari B, Soleimanifar F, Kazemi M, et al. Derivation of preoligodendrocytes from Human-Induced pluripotent stem cells through overexpression of microrna 338. J Cell Biochem. 2019;120(6):9700–9708. doi: 10.1002/jcb.28248.
   PubMed Web of Science ®Google Scholar
• Feng Z, Hua S, Li W, et al. Mesenchymal stem cells protect against TBI-induced pyroptosis in vivo and in vitro through TSG-6. Cell Commun Signal. 2022;20(1):125. doi: 10.1186/s12964-022-00931-2.
   PubMed Web of Science ®Google Scholar
• Yang W, Yin R, Zhu X, et al. Mesenchymal stem-cell-derived exosomal miR-145 inhibits atherosclerosis by targeting JAM-A. Mol Ther Nucleic Acids. 2021;23:119–131. doi: 10.1016/j.omtn.2020.10.037.
   PubMedGoogle Scholar
• Xie Q, Liu R, Jiang J, et al. What is the impact of human umbilical cord mesenchymal stem cell transplantation on clinical treatment? Stem Cell Res Ther. 2020;11(1):519. doi: 10.1186/s13287-020-02011-z.
   PubMedGoogle Scholar
• Montalbán-Hernández K, Casado-Sánchez C, Avendaño-Ortiz J, et al. Fused cells between Human-Adipose-derived mesenchymal stem cells and monocytes keep stemness properties and acquire high mobility. Int J Mol Sci. 2022;23(17):9672. doi: 10.3390/ijms23179672.
   PubMed Web of Science ®Google Scholar
• Satani N, Parsha K, Davis C, et al. Peripheral blood monocytes as a therapeutic target for marrow stromal cells in stroke patients. Front Neurol. 2022;13:958579. doi: 10.3389/fneur.2022.958579.
   PubMed Web of Science ®Google Scholar
• Sun J, Lv J, Zhang W, et al. Combination with miR-124a improves the protective action of BMSCs in rescuing injured rat podocytes from abnormal apoptosis and autophagy. J Cell Biochem. 2018;119(9):7166–7176. doi: 10.1002/jcb.26771.
   PubMed Web of Science ®Google Scholar
• Pan F, Xu W, Ding J, et al. Elucidating the progress and impact of ferroptosis in hemorrhagic stroke. Front Cell Neurosci. 2022;16:1067570. doi: 10.3389/fncel.2022.1067570.
   PubMed Web of Science ®Google Scholar
• Lu C, Tan C, Ouyang H, et al. Ferroptosis in intracerebral hemorrhage: a panoramic perspective of the metabolism, mechanism and theranostics. Aging Dis. 2022;13(5):1348–1364. doi: 10.14336/AD.2022.01302.
   PubMed Web of Science ®Google Scholar